These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women. Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877 [TBL] [Abstract][Full Text] [Related]
44. Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women. Delmas PD; Pornel B; Felsenberg D; Stakkestad JA; Radowicki S; Garnero P; Hardy P; Dain MP; Petitier B; Am J Obstet Gynecol; 2001 Jan; 184(2):32-40. PubMed ID: 11174476 [TBL] [Abstract][Full Text] [Related]
45. Effect of dose on the absorption of estradiol from a transdermal gel. Järvinen A; Granander M; Laine T; Viitanen A Maturitas; 2000 Apr; 35(1):51-6. PubMed ID: 10802400 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estrone. Boyd RA; Yang BB; Abel RB; Eldon MA; Sedman AJ; Forgue ST J Clin Pharmacol; 1996 Nov; 36(11):998-1005. PubMed ID: 8973988 [TBL] [Abstract][Full Text] [Related]
47. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Gordon SF Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298 [TBL] [Abstract][Full Text] [Related]
48. Estradiol and levonorgestrel: effects on bleeding pattern when administered in a sequential combined regimen with a new transdermal patch. van de Weijer PH; Sturdee DW; von Holst T Climacteric; 2002 Mar; 5(1):36-44. PubMed ID: 11974558 [TBL] [Abstract][Full Text] [Related]
49. Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion. Taylor MB; Gutierrez MJ Pharmacotherapy; 2008 Jun; 28(6):712-8. PubMed ID: 18503399 [TBL] [Abstract][Full Text] [Related]
50. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. Alfie J; Lugones L; Belardo A; Tutzer M; Galarza CR; Waisman GD; Cámera MI Maturitas; 1997 Jun; 27(2):163-9. PubMed ID: 9255751 [TBL] [Abstract][Full Text] [Related]
51. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Slater CC; Hodis HN; Mack WJ; Shoupe D; Paulson RJ; Stanczyk FZ Menopause; 2001; 8(3):200-3. PubMed ID: 11355042 [TBL] [Abstract][Full Text] [Related]
54. Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol. Morgan TM; O'Sullivan HM; Reed BL; Finnin BC J Pharm Sci; 1998 Oct; 87(10):1226-8. PubMed ID: 9758681 [TBL] [Abstract][Full Text] [Related]
55. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids. Rozenberg S; Ylikorkala O; Arrenbrecht S Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385 [TBL] [Abstract][Full Text] [Related]
56. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Burry KA; Patton PE; Hermsmeyer K Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1504-11. PubMed ID: 10368498 [TBL] [Abstract][Full Text] [Related]
57. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women. Stadberg E; Westlund P; Landgren BM; Aedo AR; Cekan SZ; Mattsson LA Maturitas; 1999 Sep; 33(1):59-69. PubMed ID: 10585174 [TBL] [Abstract][Full Text] [Related]
58. The effects of ethanol on the clearance of estradiol in postmenopausal women. Ginsburg ES; Walsh BW; Shea BF; Gao X; Gleason RE; Barbieri RL Fertil Steril; 1995 Jun; 63(6):1227-30. PubMed ID: 7750592 [TBL] [Abstract][Full Text] [Related]
59. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Mercuro G; Zoncu S; Pilia I; Lao A; Melis GB; Cherchi A Am J Cardiol; 1997 Sep; 80(5):652-5. PubMed ID: 9295004 [TBL] [Abstract][Full Text] [Related]
60. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K Menopause; 2006; 13(1):130-8. PubMed ID: 16607109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]